So now I have had a bit more time to read it carefully, combined...

So now I have had a bit more time to read it carefully, combined with the investor presentation on 16/5, it will be first used in the breast surgery device, which is now in clinical trial stage and making an extremely rough guess, FDA application submitted mid to late next year, and 2026 is when it all happens (ie pathology integration with both the breast and oral devices).

From what I can see, and as expected, the oral device will need further studies done, so unfortunately I can't see the FDA being all completed by next year.